| Year |
Citation |
Score |
| 2019 |
Tao P, Sun J, Wu Z, Wang S, Wang J, Li W, Pan H, Bai R, Zhang J, Wang Y, Lee PY, Ying W, Zhou Q, Hou J, Wang W, ... ... Dissanayake D, et al. A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature. PMID 31827280 DOI: 10.1038/S41586-019-1830-Y |
0.341 |
|
| 2015 |
Lind EF, Millar DG, Dissanayake D, Savage JC, Grimshaw NK, Kerr WG, Ohashi PS. miR-155 Upregulation in Dendritic Cells Is Sufficient To Break Tolerance In Vivo by Negatively Regulating SHIP1. Journal of Immunology (Baltimore, Md. : 1950). 195: 4632-40. PMID 26447227 DOI: 10.4049/Jimmunol.1302941 |
0.56 |
|
| 2014 |
Dissanayake D, Murakami K, Tran MD, Elford AR, Millar DG, Ohashi PS. Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide with adjuvant. Plos One. 9: e92380. PMID 24647761 DOI: 10.1371/Journal.Pone.0092380 |
0.55 |
|
| 2014 |
Lang P, Xu H, Grusdat M, Parish I, Recher M, Elford A, Dhanji S, Shaabani N, Tran C, Dissanayake D, Rahbar R, Ghazarian M, Brustle A, Fine J, Chen P, et al. NK cell activity promotes liver damage and chronic viral infection Zeitschrift FüR Gastroenterologie. 52. DOI: 10.1055/S-0033-1361041 |
0.494 |
|
| 2013 |
Sukhai MA, Prabha S, Hurren R, Rutledge AC, Lee AY, Sriskanthadevan S, Sun H, Wang X, Skrtic M, Seneviratne A, Cusimano M, Jhas B, Gronda M, MacLean N, Cho EE, ... ... Dissanayake D, et al. Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors Journal of Clinical Investigation. 123: 315-328. PMID 23202731 DOI: 10.1172/Jci64180 |
0.539 |
|
| 2013 |
Lin AE, Ebert G, Ow Y, Preston SP, Toe JG, Cooney JP, Scott HW, Sasaki M, Saibil SD, Dissanayake D, Kim RH, Wakeham A, You-Ten A, Shahinian A, Duncan G, et al. ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system. Nature Immunology. 14: 27-33. PMID 23179078 DOI: 10.1038/Ni.2478 |
0.542 |
|
| 2012 |
Chatterjee S, Seifried L, Feigin ME, Gibbons DL, Scuoppo C, Lin W, Rizvi ZH, Lind E, Dissanayake D, Kurie J, Ohashi P, Muthuswamy SK. Dysregulation of cell polarity proteins synergize with oncogenes or the microenvironment to induce invasive behavior in epithelial cells. Plos One. 7: e34343. PMID 22529912 DOI: 10.1371/Journal.Pone.0034343 |
0.511 |
|
| 2012 |
Lang PA, Lang KS, Xu HC, Grusdat M, Parish IA, Recher M, Elford AR, Dhanji S, Shaabani N, Tran CW, Dissanayake D, Rahbar R, Ghazarian M, Brüstle A, Fine J, et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proceedings of the National Academy of Sciences of the United States of America. 109: 1210-5. PMID 22167808 DOI: 10.1073/Pnas.1118834109 |
0.636 |
|
| 2011 |
Dissanayake D, Hall H, Berg-Brown N, Elford AR, Hamilton SR, Murakami K, Deluca LS, Gommerman JL, Ohashi PS. Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells. Nature Medicine. 17: 1663-7. PMID 22081022 DOI: 10.1038/Nm.2556 |
0.605 |
|
| 2011 |
Lin AC, Dissanayake D, Dhanji S, Elford AR, Ohashi PS. Different toll-like receptor stimuli have a profound impact on cytokines required to break tolerance and induce autoimmunity. Plos One. 6: e23940. PMID 21931625 DOI: 10.1371/Journal.Pone.0023940 |
0.599 |
|
| 2011 |
Dissanayake D, Gronski MA, Lin A, Elford AR, Ohashi PS. Immunological perspective of self versus tumor antigens: insights from the RIP-gp model. Immunological Reviews. 241: 164-79. PMID 21488897 DOI: 10.1111/J.1600-065X.2011.01014.X |
0.579 |
|
| 2011 |
Liontos LM, Dissanayake D, Ohashi PS, Weiss A, Dragone LL, McGlade CJ. The Src-like adaptor protein regulates GM-CSFR signaling and monocytic dendritic cell maturation. Journal of Immunology (Baltimore, Md. : 1950). 186: 1923-33. PMID 21220694 DOI: 10.4049/Jimmunol.0903292 |
0.582 |
|
| 2011 |
Sukhai MA, Hurren R, Rutledge A, Livak B, Wang X, Seneviratne A, Cusimano MC, Gebbia M, Skrtic M, Sun H, Gronda M, Spagnuolo PA, Urbanus M, Eppert K, Dissanayake D, et al. Lysosomal Disruption Selectively Targets Leukemia Cells and Leukemia Stem Cells Through A Mechanism Related to Increased Reactive Oxygen Species Production Blood. 118: 61-61. DOI: 10.1182/Blood.V118.21.61.61 |
0.552 |
|
| 2010 |
Sukhai MA, Li X, Hurren R, Wang X, Marko S, Sun H, Gronda M, Seneviratne A, Dissanayake D, Chow S, Bremner R, Hedley D, Minden MD, Pamela O, Schimmer A. The Anti-Malarial Mefloquine Demonstrates Preclinical Activity In Leukemia and Myeloma, and Is Dependent Upon Toll-Like Receptor Signaling for Its Cytotoxicity Blood. 116: 290-290. DOI: 10.1182/Blood.V116.21.290.290 |
0.458 |
|
| 2010 |
deLuca LS, Ng D, Gao Y, Lin A, Dissanayake D, Rahbar R, Ohashi PS, Gommerman JL. PS1-13 LT-βετα-R Signaling in dendritic cells induces a type I IFN response that integrates with CD40-derived signals for cross-priming of CD8+ T cells Cytokine. 52: 19-20. DOI: 10.1016/J.Cyto.2010.07.085 |
0.533 |
|
| 2009 |
Pellegrini M, Calzascia T, Elford AR, Shahinian A, Lin AE, Dissanayake D, Dhanji S, Nguyen LT, Gronski MA, Morre M, Assouline B, Lahl K, Sparwasser T, Ohashi PS, Mak TW. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nature Medicine. 15: 528-36. PMID 19396174 DOI: 10.1038/Nm.1953 |
0.566 |
|
| 2009 |
Pellegrini M, Calzascia T, Elford AR, Shahinian A, Lin AE, Dissanayake D, Dhanji S, Nguyen LT, Gronski MA, Morre M, Assouline B, Lahl K, Sparwasser T, Ohashi PS, Mak TW. Erratum: Corrigendum: Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies Nature Medicine. 15: 819-819. DOI: 10.1038/Nm0709-819B |
0.461 |
|
| 2007 |
Millar J, Dissanayake D, Yang TC, Grinshtein N, Evelegh C, Wan Y, Bramson J. The magnitude of the CD8+ T cell response produced by recombinant virus vectors is a function of both the antigen and the vector. Cellular Immunology. 250: 55-67. PMID 18313652 DOI: 10.1016/j.cellimm.2008.01.005 |
0.327 |
|
| 2006 |
Grinshtein N, Yang TC, Parsons R, Millar J, Denisova G, Dissanayake D, Leitch J, Wan Y, Bramson J. Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopenia. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 270-9. PMID 16297666 DOI: 10.1016/j.ymthe.2005.09.018 |
0.368 |
|
| Show low-probability matches. |